Sexual health issues after lung transplantation: Importance of cervical screening

被引:38
作者
Malouf, MA [1 ]
Hopkins, PM [1 ]
Singleton, L [1 ]
Chhajed, PN [1 ]
Plit, ML [1 ]
Glanville, AR [1 ]
机构
[1] St Vincents Hosp, Lung Transplant Unit, Sydney, NSW 2010, Australia
关键词
D O I
10.1016/j.healun.2003.07.018
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
To determine the incidence and outcomes of human papillomavirus infection and cervical abnormalities after lung transplantation, we performed a retrospective cross-sectional study of all 166 female recipients who underwent transplantation between February 1989 and June 2001 at our institution. The incidence of low-grade epithelial abnormality of the cervix, cervical intra-epithelial neoplasia (CIN) 1, and the earliest pre-cancerous changes of the cervical epithelial cells, CIN 3, in the post-transplant cohort was 42.2 and 30, respectively, per 1,000 women screened compared with 8.3 and 6.2 per 1,000 women screened (20 - 69 years old) in a large reference population. We conclude that the incidence of cervical abnormalities in lung transplant recipients is significantly greater than in the general population. The importance of regular surveillance in immunosuppressed patients to decrease the burden of disease from this potentially fatal but treatable condition is emphasized.
引用
收藏
页码:894 / 897
页数:4
相关论文
共 24 条
[1]
[Anonymous], 1992, IARC SCI PUBLICATION, V119
[2]
PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE [J].
BOSCH, FX ;
MANOS, MM ;
MUNOZ, N ;
SHERMAN, M ;
JANSEN, AM ;
PETO, J ;
SCHIFFMAN, MH ;
MORENO, V ;
KURMAN, R ;
SHAH, KV ;
ALIHONOU, E ;
BAYO, S ;
MOKHTAR, HC ;
CHICAREON, S ;
DAUDT, A ;
DELOSRIOS, E ;
GHADIRIAN, P ;
KITINYA, JN ;
KOULIBALY, M ;
NGELANGEL, C ;
TINTORE, LMP ;
RIOSDALENZ, JL ;
SARJADI ;
SCHNEIDER, A ;
TAFUR, L ;
TEYSSIE, AR ;
ROLON, PA ;
TORROELLA, M ;
TAPIA, AV ;
WABINGA, HR ;
ZATONSKI, W ;
SYLLA, B ;
VIZCAINO, P ;
MAGNIN, D ;
KALDOR, J ;
GREER, C ;
WHEELER, C .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11) :796-802
[3]
ORAL-CONTRACEPTIVE USE AND RISK OF INVASIVE CERVICAL-CANCER [J].
BRINTON, LA ;
REEVES, WC ;
BRENES, MM ;
HERRERO, R ;
DEBRITTON, RC ;
GAITAN, E ;
TENORIO, F ;
GARCIA, M ;
RAWLS, WE .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1990, 19 (01) :4-11
[4]
A NEW DEFINITION FOR AIDS SURVEILLANCE [J].
BUEHLER, JW ;
WARD, JW .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (05) :390-392
[5]
A PAPILLOMAVIRUS DNA FROM A CERVICAL-CARCINOMA AND ITS PREVALENCE IN CANCER BIOPSY SAMPLES FROM DIFFERENT GEOGRAPHIC REGIONS [J].
DURST, M ;
GISSMANN, L ;
IKENBERG, H ;
ZURHAUSEN, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (12) :3812-3815
[6]
Fait G, 1998, GYNECOL ONCOL, V70, P319, DOI 10.1006/gyno.1998.5115
[7]
Natural history of dysplasia of the uterine cervix [J].
Holowaty, P ;
Miller, AB ;
Rohan, T ;
To, T .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (03) :252-258
[8]
Bethesda classification of cervicovaginal smears: Reproducibility and viral correlates [J].
Joste, NE ;
Rushing, L ;
Granados, R ;
Zitz, JC ;
Genest, DR ;
Crum, CP ;
Cibas, ES .
HUMAN PATHOLOGY, 1996, 27 (06) :581-585
[9]
KIVLAHAN C, 1986, ACTA CYTOL, V30, P258
[10]
A controlled trial of a human papillomavirus type 16 vaccine [J].
Koutsky, LA ;
Ault, KA ;
Wheeler, CM ;
Brown, DR ;
Barr, E ;
Alvarez, FB ;
Chiacchierini, LM ;
Jansen, KU .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (21) :1645-1651